Belite’s shares have risen nearly 500% from their IPO price at a time when many other newly public biotech companies are struggling to hold their value.
( read original story …)
The Taiwan NEWS
Belite’s shares have risen nearly 500% from their IPO price at a time when many other newly public biotech companies are struggling to hold their value.
( read original story …)